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About 14% of veterans who suffer from Gulf war illness (GWI) complain of some
form of gastrointestinal disorder but with no significant markers of clinical pathology.
Our previous studies have shown that exposure to GW chemicals resulted in
altered microbiome which was associated with damage associated molecular pattern
(DAMP) release followed by neuro and gastrointestinal inflammation with loss of gut
barrier integrity. Enteric glial cells (EGC) are emerging as important regulators of the
gastrointestinal tract and have been observed to change to a reactive phenotype in
several functional gastrointestinal disorders such as IBS and IBD. This study is aimed
at investigating the role of dysbiosis associated EGC immune-activation and redox
instability in contributing to observed gastrointestinal barrier integrity loss in GWI via
altered tight junction protein expression. Using a mouse model of GWI and in vitro
studies with cultured EGC and use of antibiotics to ensure gut decontamination we show
that exposure to GW chemicals caused dysbiosis associated change in EGCs. EGCs
changed to a reactive phenotype characterized by activation of TLR4-S100β/RAGEiNOS pathway causing release of nitric oxide and activation of NOX2 since gut sterility
with antibiotics prevented this change. The resulting peroxynitrite generation led to
increased oxidative stress that triggered inflammation as shown by increased NLRP3 inflammasome activation and increased cell death. Activated EGCs in vivo and in vitro
were associated with decrease in tight junction protein occludin and selective water
channel aquaporin-3 with a concomitant increase in Claudin-2. The tight junction protein
levels were restored following a parallel treatment of GWI mice with a TLR4 inhibitor
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SsnB and butyric acid that are known to decrease the immunoactivation of EGCs. Our
study demonstrates that immune-redox mechanisms in EGC are important players in
the pathology in GWI and may be possible therapeutic targets for improving outcomes
in GWI symptom persistence.
Keywords: dysbiosis, peroxynitrite, RAGE, S100B, nitric oxide, p47 phox, SsnB, sodium butyrate

Moreover, studies have found that EGC have the ability to “sense”
a change in microbiome from probiotic to pathogenic, possibly
through toll like receptors (TLRs). A study by Turco et al.
(2014), found that adhesive E. Coli seem to activate a TLRS100β/RAGE-iNOS signaling pathway in human EGC, while
probiotic lactobacillus did not. Another study found that when
EGC were treated with lipopolysacharrides (LPS), there was
activation of TLRs with a release of S100B and nitric oxide (NO)
(Cirillo et al., 2009; Rosenbaum et al., 2016). In this reactive state,
EGC produce proinflammatory cytokines and chemokines e.g.,
(IL-1β, TNF-α, MCP-1) and release of inducible NO which may
contribute to oxidative stress in the gut (von Boyen et al., 2011;
Yu and Li, 2014; Ochoa-Cortes et al., 2016).
In irritable bowel syndrome (IBS) and inflammatory
bowel disease (IBD), it is well known that an altered
microbiome plays a significant role in the pathogenesis of
the disease (Menees and Chey, 2018). In IBS for example,
patients were found to have a decrease in abundance of
Bifidobacteria and Lactobacillus but an increased prevalence
of pathogenic species like Escherichia spp., Shigellas, and
several Clostridia (Distrutti et al., 2016). Furthermore, it
has been observed that metabolic diseases e.g., diabetes and
obesity also present with increased ratio of Firmicutes to
Bacteriodetes (Conlon and Bird, 2014; Johnson et al., 2017).
Studies concerning the mechanisms of these gastrointestinal
diseases have found that change of EGC phenotype from
homeostatic to pathogenic is a characteristic of these
diseases (Cabarrocas et al., 2003; Linan-Rico et al., 2016;
Chen et al., 2018). A study by Wang et al. reported a
significantly increased expression of glial fibrillary acidic
protein (GFAP), Tyrosine receptor kinase B and Substance
P in the colon of IBS patients with a correlated increase in
intestinal inflammation (Wang et al., 2016). Other studies
show that a loss in EGC resulted in poor gastrointestinal health
characterized by loss of gut barrier integrity (Brown et al., 2016;
Morales-Soto and Gulbransen, 2019).
Our previous research reported an altered microbiome
in a murine model of GWI with increase in Firmicutes
over Bacteriodetes and a decrease in several butyrogenic
bacteria. This dysbiosis was accompanied by activation of
TLR4, increased inflammation, a leaky gut, endotoxemia
with release of damage associated molecular patterns
(DAMPS) such as HMGB1 in gulf war chemical treated
mice compared to controls (Alhasson et al., 2017; O’Callaghan
et al., 2017; Seth et al., 2018). Interestingly, a recent study by
Hernandez et al., showed that exposure to pyridostigmine
bromide a known gulf war chemical exposure resulted
in enteric neuronal and glial reactivity and inflammation
(Hernandez et al., 2019).

INTRODUCTION
Gastrointestinal disturbances are one of the most commonly
reported chronic symptoms among veterans who returned from
the Persian Gulf war of 1990–1991 (Murphy et al., 1999; Dunphy
et al., 2003; Koch and Emory, 2005; White et al., 2016). About 14%
of veterans who suffer from Gulf War illness (GWI) complain
of some form of gastrointestinal (GI) problems such diarrhea,
pain and gas etc. (Dunphy et al., 2003; Koch and Emory,
2005). According to Coker et al. (1999), the most commonly
reported gastrointestinal issues reported among United States
and British Gulf war (GW) veterans were diarrhea, vomiting,
and stomach problems. A study by Dunphy et al. (2003) showed
veterans of the Persian GW presented with diarrhea and had
rectal hypersensitivity as did Zhou et al. (2018) who reported
increased somatic hypersensitivity and pain among some GW
veterans with GI issues.
Although the veterans report these symptoms, the prospective
study by Koch and Emory (2005) did not find any significant
clinical markers of disease pathology in blood or intestine tissue
of deployed participants. Similarly, one of our own studies which
reported metabolic reprogramming in liver as a result of leaky
gut and endotoxemia did not find any biochemical markers of
liver damage or altered metabolism in a mouse model of GWI.
This was surprising because we had had previously shown that
exposure to GW theater chemicals resulted in an alteration of gut
microbiome and concomitant TLR4 mediated gastrointestinal
and neuroinflammation with endotoxemia (Alhasson et al., 2017;
Seth et al., 2018). This elusive nature of GWI is a strong reason
for further studying underlying mechanisms of this condition in
order to obtain effective therapies.
Of emerging interest in inflammatory gastroenterology are
enteric glial cells (EGC) which reside in close proximity with
the neurons of the enteric nervous system. These cells are
similar in structure and physiology to astrocytes of the brain but
are not excitable (Gershon and Rothman, 1991; Bassotti et al.,
2007; Ochoa-Cortes et al., 2016). Initially, the principal function
of EGC was thought to be providing mechanical support to
enteric neurons. However, recent studies have shown that these
cells play an important role in regulating the gastrointestinal
microenvironment through several mechanisms, which have
been extensively reviewed (Bassotti et al., 2007; Yu and Li, 2014;
Sharkey, 2015). EGC were found to significantly modulate gut
homeostasis through release of growth factors (von Boyen et al.,
2011; Hansebout et al., 2012; Grubisic and Gulbransen, 2017)
cytokines and prostaglandins (Hansebout et al., 2012; Steinkamp
et al., 2012; Yu and Li, 2014) but may also play a pathogenic
role by contributing to nitrosative stress and proinflammatory
cytokines when exposed to stressful or toxic stimuli in the gut.
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were implemented in accordance with NIH guideline for human
care and use of laboratory animals and local IACUC standards.
All procedures were approved by The University of South
Carolina at Columbia, SC, United States. Mice were housed
individually on 7090 Sani-Chip bedding from Teklad (Madison,
WI, United States) and fed with 8904 irradiated chow diet from
Teklad (Madison, WI, United States) at 22–24◦ C with a 12h light/12-h dark cycle. All mice were sacrificed after animal
experiments had been completed. Immediately after terminal
anesthesia, mice’s small intestine was collected and dissected for
further experiments, while fecal pellets were collected from the
colon and immediately stored in sterile Eppendorf tubes for
microbiome analysis. The tissues were fixed using 10% neutral
buffered formalin. Distal segments of small intestines were used
for the staining and visualizations.

This current study investigates the contribution of EGC
in observed inflammatory phenotype which we and others
have observed in GWI. We test the hypothesis that, the
altered microbiome which results in increased pathogen
associated molecular patterns (PAMPS) (e.g., LPS, flagellin
and other immunostimulatory bacterial parts), leaky gut and
increase in circulatory DAMPS (e.g., HMGB-1) in GWchemical (Permethrin and pyridostigmine bromide) treated
mice results in a reactive EGC phenotype compared to
mice treated with vehicle control treated mice and mice coexposed with GW chemicals and antibiotics. Through this
reactive EGC phenotype intestinal cells such as enteric neurons
and epithelial cells might be further affected leading to a
vicious cycle of consistent proinflammatory state. This constant
proinflammatory state of intestinal cells might answer the
persistence of gastrointestinal, systemic and neuro inflammation
in gulf war illness. The study uses a murine model of GWI
and in vitro studies with EGCs and intestinal epithelial cells
to elucidate possible mechanisms to explain this observed
inflammation observed in GWI.

Rodent Model of Gulf War Illness (GWI)
Mice were exposed to Gulf War chemicals based on established
rodent models of Gulf War Illness with some modifications
(Zakirova et al., 2015; O’Callaghan et al., 2017). The treated
wild-type mice group (GW) were dosed tri-weekly for 1 week
with PB (2mg/Kg) and Permethrin (200 mg/kg) by oral gavage.
After completion of PB and Permethrin dosages, mice were
administered corticosterone intraperitoneally (i.p.) with a dose
of 100µg/mice/day for 5 days of the week for 1 week to
represent war stress. The dose of corticosterone was selected from
the study which exposed mice to 200 mg/L of corticosterone
through drinking water. The i.p. dose of corticosterone had
similar immunosuppression as examined by low splenic T
cell proliferation (data not shown). The vehicle control group
(CONT) of mice received saline injections and vehicle for oral
gavage (6% DMSO) in the same paradigm. Similarly, another
group of mice (GW + AB) were exposed to PB/Permethrin
and corticosterone as in above mentioned dosages along with
antibiotics (Neomycin 45 mg/kg and Enrofloxacin 1mg/Kg)
thrice per week for 2 weeks for intestinal decontamination
and obtaining gut sterility, while another group (AB) were
exposed to antibiotics (Neomycin, 45 mg/kg and Enrofloxacin
1 mg/Kg) for 2 weeks. A fifth group of mice was treated
with PB/Permethrin and corticosterone, but with Sodium
butyrate (10 mg/Kg) and Sparstolonin B (SsnB) 3 mg/Kg
(GW + SsnB + BT). We have shown before that SSnB is
a potent TLR4 antagonist and Butyrate decreases intestinal
inflammation in GWI.

MATERIALS AND METHODS
Pyridostigmine bromide (PB), Permethrin (Per), Sodium
Butyrate, Sparstolonin B (SsnB), Corticosterone, Neomycin
trisulfate hydrate, Enrofloxacin, Apocynin (APO), Phenylboronic
acid (FBA) were purchased from Sigma-Aldrich (St. Louis, MO,
United States). Lipopolysaccharides (LPS), LPS-RS (TLR4
inhibibitor) were purchased from Cayman chemical company
(Ann Arbor, MI, United States), Rat High mobility group
box 1 protein (HMGB-1) Rat (rec) (His) was purchased from
Chimirigen, Mediatech, Inc. (Manassas, VA, United States), AntiTLR4, anti-flotillin-1, anti-S100B, anti-GFAP, anti-ASCII and
anti-Caspase 1, anti-TLR5, anti-3NT, anti-GP91, anti-P47phox,
anti-NOS 2, anti-HMGB-1 and anti-aquaporin-3 primary
antibodies were purchased from Santa Cruz Biotechnology
(Dallas, TX, United States), anti-claudin 2, anti-TLR2 and antioccludin were purchased from Abclonal Technology (Woburn,
MA, United States) was while anti-NLRP-3, anti-RAGE were
purchased from Abcam (Cambridge, MA, United States).
Fluorescence-conjugated (Alexa Fluor) secondary antibodies,
ProLong Gold antifade mounting media with DAPI were
purchased from Thermofisher Scientific (Grand Island, NY,
United States), Apoptosis ApopTag Fluorecein in situ detection
kit from Millipore (Billerica, MA, United States), The Pierce
LAL Chromogenic Endotoxin Quantification Kit from Thermo
Scientific (Waltham, MA, United States) and Griess reagent
system from Promega corporation (Madison, WI). All other
chemicals which were used in this study were purchased from
Sigma unless otherwise specified. Paraffin-embedding of tissue
sections on slides were done by AML laboratories (Baltimore,
MD, United States).
R

Cell Culture
Enteric Glial Cell Culture
Immortalized rat EGC were obtained from ATCC (ATCCCRL2690). Plated EGC were maintained in DMEM media
supplemented with 10% FBS until treated. Cells were serum
starved in DMEM supplemented with 1% FBS for 12 h and then
exposed to vehicle control and chemicals. Cells were then treated
with vehicle control-PBS (VEH), LPS (1 µg/mL), HMGB-1
(100 ng/mL), SsnB (10 µg/mL), Sodium butyrate (5 mM)and
inhibitors FBA (100 µM) and Apocynin (100 µM) with either
HMGB-1, LPS or antibiotics (neomycin and enrofloxacin
cocktail) at different dilutions ranging from (1X to 1000X)
R

Animals
Adult wild-type male (C57BL/6J mice) were purchased from
the Jackson Laboratories (Bar Harbor, ME, United States). Mice
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Second Genome for 16S rRNA sequencing. Microbial analyses
were performed from isolated nucleic acids using the MoBio
PowerMag Microbiome kit (Carlsbad, CA, United States),
according to manufacturer’s instructions. The microbiome data
is in NCBI EBI under the accession number PRJEB19474.

TABLE 1 | Rat primer sequence.
Rat_IL-1β

Sense: CCTCGGCCAAGACAGGTCGC

Rat_NLRP-3

Sense: TGCATGCCGTATCTGGTTGT

Antisense: TGCCCATCAGAGGCAAGGAGGA
Antisense: ATGTCCTGAGCCATGGAAGC
Rat_TNF-α

Sense: CAACGCCCTCCTGGCCAACG

Laboratory Methods

Antisense: TCGGGGCAGCCTTGTCCCTT
Rat_ASCII

Immunofluorescence Staining

Sense: GGACAGTACCAGGCAGTTCG

Paraffin-embedded distal part of the small intestine sections
were deparaffinized using a standard protocol. Epitope retrieval
solution and steamer were used for epitope retrieval of
sections. Primary antibodies such as anti- GFAP, antiS100β, anti-NOS2, anti-NLRP-3, anti-ASCII, anti-GP91,
anti-P47phox anti-TLR4, anti-Flotillin, anti-aquaporin3
were used at the recommended dilution (1:200). Speciesspecific secondary antibodies conjugated with Alexa Fluor
(633-red and 488-green) were used at advised dilution
(1:300). Finally, the stained sections were mounted using
Prolong gold anti-fade reagent with DAPI. Sections were
observed under–Olympus fluorescence microscope using
20X, 40X or 60X objective lenses, or under confocal
microscopy using Leica SP-8 with LasX-10 software at
magnification of 63X.

Antisense: GTCACCAAGTAGGGCTGTGT
Rat_Caspase 1

Sense: GACAGGTCCTGAGGCCAAAG

Rat_MCP 1

Sense: TAGCATCCACGTGCTGTCTC

Rat_18S

Sense: GGATCCATTGGAGGGCAAGT

Rat_NOS2

Sense: AGCAGAGTTGGTGCAGAAGC

Rat_Claudin1

Sense: AGGTCTGGCGACATTAGTGG

Rat-ZO-1

Sense: GGAAATGTGTAAATCACCTGGAAGA

mm_18S

Sense: TTCGAACGAACGTCTGCCCTATCAA

mm_Claudin1

Sense: TTTCGCAAA GCACCGGGCATACA

mm_ZO-1

Sense: CCACCTCTGTCCAGCTCTTC

Antisense: AAAAGTTCATCCAGCAATCCATTT
Antisense: CAGCCGACTCATTGGGATC
Antisense: ACGAGCTTTTTAACTGCAGCAA
Antisense: GGGAATAGCACCTGGGTTTT
Antisense: CGTGGTGTTGGGTAAGAGGT
Antisense: CCAAAGAACAGAAGACCACCAAC
Antisense: ATGGTAGGCACGGCGATA

Western Blot

Antisense: GCCACTAATGTCGCCAGACCTGAAA

Serum HMGB-1 levels were estimated from 35 µg of denatured
mouse serum protein, while TLR2, 4 and 5 were estimated
from 25 µg of denatured small intestine tissue by a Western
Blot analysis following standard protocols. Briefly, serum
was concentrated and then diluted 1:5. Tissue protein or
serum protein was then separated on a Novex 4–12% bistris gradient gel and subjected to standard SDS-PAGE. The
separated proteins were then transferred to a nitrocellulose
membrane by a Trans-Blot Turbo transfer system. The
membrane was then stained with Ponceau S, and then
blocked with 5% BSA solution for 1 h, then incubated with
primary antibody overnight at 4◦ C. Species-specific anti-IgG
secondary antibody conjugated with HRP was used to tag
primary antibody. ECL western blotting substrate was used
to develop the blot The blot was then imaged using G:Box
Chemi XX6 and subjected to densitometry analysis using
Image J software.

Antisense: CACCGGAGTGATGGTTTTCT
mm_TLR2

Sense: ACCAAGATCCAGAAGAGCCA

mm-TLR4

Sense: GGAGTGCCCGCTTTCACCTC

mm-TLR5

Sense: TGTAAAGTACTGGTGCCCGTGTGT

mm-NOS-2

Sense: CGCTGGCTACCAGATGCCCG

Antisense: CATCACCCGGTCAGAAAACAA
Antisense: ACCTTCCGGCTCTTGTGGAAGC
Antisense: ACTGCGCAAACATTCTGCTGGC
Antisense: GCCATAGCGGGCTTCCAGC
The primer sequences are given as 50 -30 orientation; Sense: Forward primer.
Antisense: Reverse primer.

(see Supplementary Figures S2–S7) for 24 h. After which the
experiment was terminated and cells were harvested for mRNA
extraction, gene expression analysis and protein expression
studies. Nitric oxide production was estimated from culture
fluids by measuring nitrite formation using the Griess assay.

Real-Time Quantitative PCR
Messenger RNA expression in small intestine and rat EGC
was examined by quantitative real-time PCR analysis. Total
RNA was isolated from each 15 mg small intestine tissue or
1 × 106 EGC by homogenization in Trizol reagent (Invitrogen,
Carlsbad, CA, United States) according to the manufacturer’s
instructions and purified with the use of RNeasy mini kit
columns (Qiagen, Valencia, CA, United States). cDNA was
synthesized from purified RNA (1 µg) using iScript cDNA
synthesis kit (Bio-Rad, Hercules, CA, United States) following the
manufacturer’s standard protocol. Real-time qPCR (qRTPCR)
was performed with the gene-specific primers using SsoAdvanced
SYBR Green Supermix and CFX96 thermal cycler (Bio-Rad,
Hercules, CA, United States). Threshold Cycle (Ct) values for

Intestinal Epithelial Cell Culture
Immortalized rat intestinal epithelial cells (IEC-6) ATCC© CRL1592, were obtained from ATCC. The cells were maintained in
DMEM media supplemented with 10% FBS and 1x ITS until
treated. Cells were serum starved in DMEM supplemented with
1% FBS for 12 h and then primed with LPS (100 ng/mL) for 12 h.
Cells were then treated with culture fluids from EGC (above) for
24 h, then harvested for further analyses.

Microbiome Analysis
Microbiome was analyzed from fecal pellets and luminal
contents collected from animals after sacrifice and sent to
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FIGURE 1 | Altered microbiome associated increase PAMPS and DAMPS. (A) Stool endotoxin levels. Endotoxin levels in stool samples were determined by the LAL
assay. Graph (A) show the levels of endotoxin in Endotoxin Units (Eu) in vehicle control (CONT, n = 9) treated mice, gulf war chemical exposed mice (GW, n = 9) and
mice co-exposed with antibiotics (GW + AB, n = 9) (∗ P < 0.05). (B) Expression of HMGB-1 in small intestine tissues. Expression of HMGB1 was assessed by
immunofluorescence microscopy at (total Magnification 200X; scale bar 100 µm). Images show immunoreactivity in the distal part of the small intestine for vehicle
control treated mice (CONT, n = 9), GW chemical treated mice (GW, n = 9) and mice co-exposed with gulf war chemicals and antibiotics (GW, n = 9). (C) Quantitative
morphometric analysis of HMGB-1 immunoreactivity represented as arbitrary light units in the region of interest (% ROI) ∗ P < 0.05. (D) Serum High mobility group
box 1 (HMGB1) levels. Serum HMGB-1 levels were estimated by western blot analysis for mice treated with control (CONT, n = 3), Gulf war chemical exposed mice
(GW, n = 5) and mice co-exposed to antibiotics and GW chemicals (GW + AB, n = 3). Ponceau red staining was used for normalization of protein. (E) Quantitative
morphometric analysis of western blot bands normalized against total Ponceau. The Y axis shows HMGB-1/Ponceau S ratio (∗ P < 0.05).
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FIGURE 2 | Altered microbiome induced change in EGC phenotype to a reactive phenotype. (A) Expression GFAP. Expression of GFAP was assessed by
immunofluorescence microscopy at (top panel magnification 200X; scale 100 µm and bottom panel magnification 600X; scale 20 µm). Images show
immunoreactivity of the distal part of the small intestine for vehicle control treated (CONT, n = 9), gulf war chemical treated mice (GW, n = 9), mice treated with only
antibiotics (AB, n = 4) and mice co-exposed with gulf war chemicals and antibiotics (GW + AB, n = 9). (B) Quantitative morphometric analysis of GFAP
immunoreactivity represented as arbitrary light units as observed in the region of interest (% ROI) (∗ P < 0.05).

the selected genes were normalized against respective samples
internal control (18S). Each reaction was carried out in triplicates
for each gene and for each sample. The relative fold change
was calculated by the 2-11Ct method. The sequences for
the primers used for Real-time PCR are provided below
in Table 1.

Nitrite Estimation by Griess Assay
Nitric oxide release was estimated from the cell culture
fluids by measuring nitrite formation immediately after the
experiment was terminated. Nitrite was measured using the
Griess reagent system from Promega corporation (Madison, WI,
United States) and experiments were performed according to
manufacturer’s protocols.

Endotoxin Level Detection by Litmus
Amebocyte Lysate Assay

Tunel Assay
DNA fragmentation was detected using the ApopTag
Fluorescein in situ detection kit from Millipore (Billerica, MA,
United States) by following the manufacturer’s standard protocol.
R

Bacterial endotoxins (EU/mL) were detecte din mouse
stool samples for mice which were treated with vehicle
control, gulf war chemicals, and mice co-exposed with
gulf war chemicals and antibiotics using the Pierce LAL
Chromogenic Endotoxin Quantification Kit according to
the manufacturer’s instructions. Briefly, stool samples were
obtained from mice and equal weights were homogenized
in endotoxin free water. The supernatant was then collected,
and heat inactivated at 70◦ C. This was then diluted 1:300 and
endotoxins quantified.

Frontiers in Physiology | www.frontiersin.org

Statistical Analysis
All in vivo experiments were repeated three times (N = 3) with at
least 3 mice per group (n = 9; data from each group of three mice
were pooled). All in vitro and laboratory analysis experiments
were repeated at least three or four times. The statistical
analysis was carried out by analysis of variance (ANOVA)
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FIGURE 3 | Expression of Toll-like receptors in small intestine and EGC. (A,B) General mRNA and protein expression levels of toll-like receptors TLR2, TLR4, and
TLR5 in small intestine of mice treated with vehicle control (CONT, n = 9), gulf war chemical treated mice (GW, n = 9) and mice treated with antibiotics only (AB,
n = 4) and mice co-exposed with GW chemicals and antibiotics (GW + AB, n = 9). mRNA expression was determined by RTqPCR, while protein expression was
determined by western blot analysis. (E) Quantitative morphometric analysis of western blot bands normalized against β-actin The Y axis shows protein/β-actin ratio
Results are expressed as mean ± SEM for n = 9 (∗ P < 0.05). (C) Tissue level expression of TLR4 in EGC in small intestine. Expression of TLR4 in EGC was observed
by in dual labeling of TLR4 and EGC cells marker GFAP via immunofluorescent microscopy visualized at (top panel magnification 200X; scale 100 µm and bottom
panel magnification 600X; scale 20 µm) in small intestine tissues obtained from mice treated with vehicle control (CONT, n = 9); mice treated with GW chemicals
(GW, n = 9) mice, mice treated with antibiotics only (n = 4) and co-exposed with GW chemicals and antibiotics (GW + AB, n = 3). (D) Quantitative morphometric
analysis of immunoreactivity of GFAP/TLR4 (yellow) is represented as colocalizations events per field from randomly chosen microscopic fields (∗ P < 0.05).

(see Supplementary Table S1 for F-statistics) and a Turkey’s
HSD test to determine specific group differences. Further we
performed an unpaired student t-test, using Graph pad prism

Frontiers in Physiology | www.frontiersin.org

software (GraphPad Software Inc., La Jolla, CA, United States).
For all analyses ∗ P < 0.05 was considered statistically significant
and are marked as (∗ ).
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FIGURE 4 | (A) Expression levels of S100B in EGC. Protein expression levels of S100B in EGC was determined by co-staining S100B with GFAP and assessed by
immunofluorescence microscopy at (top panel magnification 200X; scale 100 µm and bottom panel magnification 600X; scale 20 µm). Images show
immunoreactivity in distal part of the small intestine for vehicle control treated mice (CONT, n = 9), gulf war chemical treated mice (GW, n = 9) and gulf war chemical
treated mice, mice treated with antibiotics only (AB, n = 4) and mice co-exposed with antibiotics (GW + AB, n = 9). (C) Quantitative morphometric analysis of
immunoreactivity of GFAP/S100B (yellow) is represented as colocalizations events per field from randomly chosen microscopic fields (% ROI) (∗ P < 0.05). (B)
Expression of RAGE in EGC Protein expression levels of RAGE in EGC was determined by co-staining RAGE with GFAP and assessed by immunofluorescence
microscopy at (top panel magnification 200X; scale 50 µm and bottom panel magnification 600X; scale 20 µm). Images show immunoreactivity in distal part of the
small intestine for vehicle control treated mice (CONT, n = 9), gulf war chemical treated mice (GW, n = 9) mice treated with antibiotics only (AB, n = 4) and gulf war
chemical treated mice co-exposed with antibiotics (GW + AB, n = 3). (D) Corresponding quantitative morphometric analysis of immunoreactivity of GFAP/RAGE
(yellow) is represented as colocalizations events per field from randomly chosen microscopic fields (% ROI) (∗ P < 0.05).

endotoxin levels (PAMPS e.g., LPS) in the stools of mice
which were treated with GW chemicals in comparison with
the controls and found that there was a significant increase
in endotoxin levels of mice treated with GW chemicals
compared to the controls (Figure 1A; P < 0.05). We further
assessed the amount of HMGB-1 which was released in
the small intestine (Figures 1B,C) using immunofluorescence
microscopy and in the blood circulation (Figures 1D,E)
using a western blot analysis for serum HMGB-1 levels
in the circulation. These high amounts of DAMPS and

RESULTS
Altered Microbiome Is Associated With
Increase in PAMPs and DAMPs in Gulf
War Chemical Exposed Mice
Studies have shown an association between altered
microbiome and increase in endotoxin levels in serum or
feces (Palone et al., 2016; Palone et al., 2018; Seth et al.,
2018). In this study, using the LAL assay, we estimated the
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FIGURE 5 | Formation of S100B/RAGE complex in small intestine. (A) S100B(Green)/RAGE(Red) complex formation expression in EGC in small intestine tissues.
Protein expression levels were assessed by immunofluorescence microscopy of tissues at (top panel magnification 200X; scale 50 µm and bottom panel
magnification 600X; scale 20 µm). Images show immunoreactivity the distal part of the small intestine for gulf war chemical treated mice (GW, n = 9), vehicle control
(CONT, n = 9), mice treated with antibiotics only (n = 4) and mice co-exposed GW chemicals and antibiotics (GW + AB, n = 9). (B) Quantitative morphometric
analysis of immunoreactivity for S100B/RAGE is represented as colocalization events per field for randomly chosen fields (% ROI) (∗ P < 0.05).

PAMPS in the body will reach the EGC and cause persistent
glial reactivity.

a reactive EGC phenotype in IBS and IBD (Akimoto, 2000;
von Boyen et al., 2011).

Altered Microbiome (Dysbiosis)
Correlates With an Increased Expression
of GFAP While Gut Decontamination
With Antibiotics Decreases GFAP in
Intestinal Enteric Glial Cells

Altered Microbiome Correlates With a
Reactive EGC Phenotype Through
Activation of Toll-Like Receptors While
Gut Decontamination via Antibiotic
Usage Reversed Activation

Enteric glial cells which are found in close proximity with
enteric neurons are very abundant in the lamina propria, mucosa
and sub mucosal regions of the small intestine (Bassotti et al.,
2007). Using immunofluorescence microscopy, we found that
there was a significant increase (P < 0.05) in GFAP expression
in the small intestine of mice treated with GW chemicals
(PB + BER) compared to the control group, and mice coexposed to GW chemicals and antibiotics (Figures 2A,B). The
increased expression of this protein has been associated with

Our previous studies showed that the altered microbiome was
associated with an activation of Toll like receptors such as TLR4
and TLR5 in GW chemical treated mice (Dyer and Walker,
1993; Seth et al., 2018). In this study we show that there was a
significant increase mRNA (Figure 3A) and protein expression
(Figures 3B,E) levels of TLR 2, 4, and 5 in mice which were
exposed to gulf war chemicals (Permethrin and pyridostigmine
bromide) compared to mice treated with only vehicle control and
mice co exposed with GW chemicals and antibiotics (P < 0.05).
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FIGURE 6 | Activation of NOS-2 in small intestine. (A) NOS-2 mRNA expression in the small intestine of intestine of mice treated with vehicle control (CONT, n = 9),
gulf war chemical treated mice (GW, n = 9), mice treated with antibiotics only (AB, n = 4) and mice co-exposed with GW chemicals and antibiotics (GW + AB, n = 9.
∗ P < 0.05) was determined by RTqPCR. (B) Protein expression levels of NOS- 2 in enteric glial cells was determined by immunofluorescence microscopy of tissues
and imaged at (top panel magnification 200X; scale 50 µm and bottom panel magnification 600X; scale 20 µm). (C) Quantitative morphometric analysis of
immunoreactivity for GFAP/NOS-2 represented as colocalization events per field for randomly chosen fields (% ROI).

We further detected a significant increased expression of TLR4
on EGC (TLR4/GFAP colocalizations) in GW chemical treated
(GW) mice compared to Vehicle (CONT) and mice co-exposed
with GW chemicals and antibiotics (GW + AB) (P < 0.05)
(Figures 3C,D) by immunofluorescence microscopy.

chemical treated mice compared to mice treated with vehicle
control and mice which were co exposed with GW chemicals and
antibiotics (P < 0.05) (Figures 4A,C). We also found that there
was a significant increase in RAGE expression in GW chemical
treated mice in EGC by co-staining RAGE and GFAP (P < 0.05)
compared to vehicle control treated mice. However, this increase
was not significant for mice treated with both GW chemicals and
antibiotics (Figures 4B,D).
We then studied the interaction between RAGE and S100B
using immunofluorescence microscopy assuming that a colocalization of these two proteins would suggest complex
formation and aid interaction. We showed that there was
significant increase (P < 0.05) in S100β/RAGE complex
formation in GW chemical exposed mice (GW) and mice
treated with vehicle control (CONT) or mice co-exposed with

Altered Microbiome Associated
Increased Expression of S100B in
Reactive EGC Resulting in NOS-2
Expression While Antibiotic Usage for
Depletion of Bacteria Reversed Such
Activation
Using immunofluorescence microscopy, we found that there
was a significant increase in the expression of S100B in GW
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response through toll like receptors or NOD-like receptors
(Turco et al., 2014).
Using immunofluorescence microscopy, we found that there
was significant increase in TLR4 expression when we treated rat
EGC with LPS or HMGB-1 (Figures 7A,B, P < 0.05). We also
found an increase in S100β/RAGE complex formation in LPS
and HMGB1 treated cells compared to cells treated with vehicle
control (P < 0.05) (Figures 8A–C). However, the difference
between expression of these receptors was not significantly
different between the cells treated with HMGB1 alone compared
to those treated with HMGB1 + LPS-RS to block the TLR4
receptor. This indicates that possibly, DAMPS like HMGB1
can trigger inflammatory pathways in EGCs via several other
receptors apart from TLR4.
We further evaluated the activation of inducible nitric oxide
synthase and release of nitric oxide in the rat EGC treated with
LPS or HMGB1 (Figures 9A–D). We used RT q PCR to evaluate
the expression of nitric oxide synthase in rat EGC (Figure 9A).
Our results showed a significant increase in the expression of
iNOS in cells treated with LPS or HMGB1 compared to vehicle
control (P < 0.01). We also found that there was a significant
increase in the protein expression of NOS-2 in LPS and HMGB-1
treated cells compared to cells treated with vehicle control only
as evaluated by immunofluorescence microscopy (Figures 9B,C)
(n = 3, P < 0.05). Finally, we investigated whether there was a
release of nitric oxide by the cells (Figure 9D). We found that NO
release was significantly increased LPS (2.6 fold) (∗ P < 0.05), but
only a marked increase in cells treated with HMGB1 (P = 0.07)
compared to vehicle control treated cells. Together, these results
indicate the activation of a TLR-S100B/RAGE pathway that
subsequently led to the increased production of nitric oxide,
especially in response to microbial PAMPS.

FIGURE 7 | Exposure to DAMPS and PAMPS cause activation of TLR4 in
EGC. (A) TLR4 activation in rat Enteric Glial Cells (EGC) (n = 6). Colocalization
of TLR4 and Flotillin in EGC treated with either vehicle control (VEH) or LPS,
LPS + LPS-RS, HMGB-1 or HMGB1 + LPS-RS determined by
immunofluorescence microscopy at (magnification 400X; scale 50 µm). (B)
Quantitative morphometric analysis of TLR4/Flotillin colocalizations between
red and green immunoreactivity were determined for every 100 cells per field.
Fields were chosen randomly, and colocalizations represented as
immunoreactivity in the region of interest (% ROI) (∗ P < 0.05).

GW chemicals and antibiotics (GW + AB) (Figures 5A,B). In
Figure 6A using RTqPCR we found that there was a significant
increase in mRNA expression of inducible nitric oxide synthase in
the small intestine of GW chemical treated mice and mice treated
with vehicle control and mice co exposed with antibiotics and
gulf war chemicals (n = 9, p < 0.05). Further, we showed that
there was a marked increase in inducible nitric oxide synthase
(NOS-2) expression in the intestine tissues of mice treated with
GW chemicals (GW) compared to mice treated with vehicle
control (CONT) and mice co-exposed with GW chemicals and
antibiotics (GW + AB), although this increase was not significant
(P = 0.075, and 0.11 respectively) (Figures 6B,C).
These results are evidence of activation of a TLRS100β/RAGE-iNOS pathway in association to an altered
microbiome in vivo as suggested by a decrease of activation
following the use of antibiotics to ensure gut decontamination.

Activation of NADPH Oxidase 2 (NOX-2)
and Increased Peroxynitrite Formation in
Small Intestine Following Dysbiosis and
Its Reversal by Gut Sterility
NADPH oxidase-2 with its subunits P47 phox, P67 phox,
P22 align with GP91 in the membrane to form the NOX2 membrane assembly. We detected the activation of NOX2 by immunofluorescence dual labeling of GP91phox and
P47phox subunits of the enzyme. We found a significant increase
(P < 0.05) GP91phox-P47phox co-localization events in GW
chemical treated mice (GW) compared to mice treated with
vehicle (CONT, n = 9), mice exposed to antibiotics only (AB,
n = 4) and mice co-exposed with GW chemicals and antibiotics
(GW + AB, n = 9) (Figures 10A,B). Furthermore, we found a
marked increase in peroxynitrite, an indicator of redox sensitive
tyrosyl radicals in EGC of mice treated with GW chemicals
compared to mice treated with either vehicle control or GW
chemicals and antibiotics (Figures 10C,D) (∗ P < 0.05).

Exposure to PAMPS (e.g.,
Lipopolysaccharides) and DAMPS (e.g.,
HMGB-1) Causes the Activation of
TLR4-s100β/RAGE-NO Pathway in EGC

Activation of NOX-2 and Increased
Peroxynitrite Formation in Rat EGC

EGC can respond to an over balance in gut microorganisms by
detecting PAMPS on/from the pathogen these bacteria such as
cell wall, nucleic acid, flagella etc and mount an effective immune
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Studies have showed that NADPH oxidases are activated
in response to pathogenic stimuli in human EGC
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FIGURE 8 | EGC exposed to LPS or HMGB-1 change to a reactive phenotype. (A) S100B/RAGE complex formation in rat Enteric Glial Cells (EGC) (n = 6).
Colocalization of S100β and RAGE in EGC treated with either vehicle control (VEH) or LPS, LPS + LPS-RS, HMGB1 or HMGB-1 + HMGB-1 + LPS-RS was
determined by immunofluorescence microscopy at (total magnification 400X and scale 20 µm). (B,C) Quantitative morphometric analysis of S100B/RAGE complex
formation. Colocalizations between red and green immunoreactivity were determined for every 100 cells per field for randomly chosen fields and represented as
immunoreactivity in the region of interest (% ROI) (∗ P < 0.05).

tyrosyl radical and subsequent formation of tyrosine nitration
We also observed that there was a significant increase in
formation of peroxynitrite (shown by increased 3- nitrotyrosine
formation) in LPS or HMGB1 treated EGC compared to Vehicle
control (VEH) treated and LPS or HMGB1 and apocynin
(LPS + APO) or (HMGB1 + APO) (Figures 12A–D) treated
EGC (P < 0.05, n = 6).

(Macchioni et al., 2017). We found that treatment of EGC
with LPS or HMGB1 significantly increased their expression
of NOX-2 (Figures 11A–D) (P < 0.05). This activation was
observed by immunofluorescence microscopy by detecting
co-localization events (per 100 cells) between two key subunits
of the NOX-2 enzyme complex. One in the lipid membrane
GP91phox (labeled with green secondary antibody) and P47phox
(labeled with red antibody). We found a significant increase
in these co-localizations in LPS or HMGB1 treated cells
compared to vehicle control treated cells (VEH) and cells treated
with LPS/HMGB1 and Apocynin (LPS + APO) a NADPH
inhibitor (Apocynin blocks the transport of p47 phox to the
membrane) (∗ P < 0.05).
NOX-2 induced superoxide and nitric oxide react rapidly to
form peroxynitrite, an indicator of redox related formation of

Frontiers in Physiology | www.frontiersin.org

Oxidative Stress Triggers Activation of
NLRP-3 Inflammasome Which Results in
Increased Inflammation
Reactive oxygen species (ROS) can trigger activation of
inflammasomes resulting in caspase 1 mediated cleavage
of Il-1β and IL-18 proinflamatory cytokines (Abais et al.,
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FIGURE 9 | Activation of inducible nitric oxide synthase by LPS or HMGB-1. (A) mRNA expression of NOS-2 in EGC exposed to vehicle control (VEH), LPS,
LPS + LPS-RS or HMGB-1 and HMGB-1 + LPS-RS (n = 6) expressed as x fold of the vehicle control. mRNA expression was determined by qRTPCR. (B) NOS-2
protein expression in the cells was detected by staining with green fluorescent antibody and counterstained with DAPI (blue) and viewed at (total magnification 400
µm and scale 20 µm). (C) Quantitative morphometric analysis of NOS-2 in rat EGC per 100 cells in different fields and represented as immunoreactivity in the region
of interest (% ROI). (D) Nitrite concentration in EGC (n = 8). Nitric oxide production in EGC supernatants was estimated by Griess assay from freshly harvested
supernatants. Nitrite concentration is reported as X fold increase over the vehicle control (VEH) (∗ P < 0.05).

compared to the vehicle control (P > 0.05). Treatment
of EGC with LPS and apocynin (LPS + APO) and FBA
(LPS + FBA) significantly decreased the observed mRNA
expression (P < 0.05).

2015). Our results (Figures 13A,B) showed significant
increase in mRNA expression of NLRP-3, Caspase-1, IL-1β
and TNF-α in LPS treated EGC but not HMGB1 treated
cells which only showed an increase in TNF-α expression
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FIGURE 10 | NADPH oxidase 2 and peroxynitrite mediated oxidative stress in vivo. (A) NOX-2 activation in small intestine assessed by immunofluorescence
microscopy (n = 9) (at total magnification 200X and scale 50 µm). Activation of NOX 2 was studied through observing colocalizations between GP91phox (labeled
with green fluorescent antibody) and P47 phox (labeled with red fluorescent antibody) subunits of the NADPH 2 oxidase complex resulting in a yellow region.
Colocalizations were determined in small intestine tissues of CONT, GW, AB, and GW + AB chemical exposed mice. (B) Graphical representation of morphometric
analysis of colocalization events of GP91phox and P47phox in the region of interest. (C) Immunoreactivity of 3-nitrotyrosine (3NT) in EGC assessed through
observing colocalizations between GFAP (labeled with green fluorescent antibody) and 3NT phox (labeled with red fluorescent antibody) at top panel magnification
200X, scale 50 µm and bottom panel magnification 600X and scale 20 µm) Colocalizations were determined in small intestine tissues of CONT, GW, AB, and
GW + AB chemical exposed mice. (D) Graphical representation of morphometric analysis of colocalization events of GFAP (green) and 3NT (red).

We then investigated the protein expression of NLRP3 and ASCII and adaptor protein of NLRP-3 in rat
EGC using immunofluorescence microscopy. We found
that cells treated with LPS but not HMGB1 treated
cells showed a significant increase in NLRP-3 and

Frontiers in Physiology | www.frontiersin.org

ASCII complex formation compared to Vehicle control
treated cells (VEH) indicating activation of the NLRP3 inflammasome, when EGC encounter PAMPS. We
further found that treatment of cells with LPS and FBA
(LPS + FBA) showed a significant decrease in NLRP-3
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FIGURE 11 | NADPH oxidase 2 activation in rat EGC. (A,B) Activation of NOX-2 in rat EGC (n = 6). Activation of NOX 2 was studied through observing
colocalizations between GP91phox (labeled with green fluorescent antibody) and P47 phox (labeled with red fluorescent antibody) subunits of the NADPH 2 oxidase
complex resulting in a yellow region. Colocalization (yellow) of GP91phox and P47phox was detected in vehicle VEH, LPS, LPS + apocynin (LPS + APO), HMGB-1,
HMGB-1 + APO treated cells at total magnification 400X; scale 20 µm). (C,D) Morphometric analysis of GP91/p47phox colocalization events in rat EGC per 100
cells in different fields (∗ P < 0.05).

protein activation (P < 0.05), (Figures 13C–E) suggesting the
role of NOX-2 derived peroxynitrite as a candidate for the
inflammasome formation.

when cells were treated with HMGB1 and apocynin or FBA, there
where was no significant decrease in tunel events.

Increased DNA Fragmentation in
Reactive Rat EGC Following Stimulation
With LPS and Its Dependence on
NOX-2-Induced Oxidative Stress

Reactive EGC Contribute to
Inflammation and Intestinal Barrier
Integrity in Small Intestine: Gut
Decontamination by Antibiotics and
Blocking EGC Immune Activation
Restores Gut Barrier Protein Levels in
GWI Mice

Increased pathogenic stimuli were found to initiate apoptosis
in EGC (Macchioni et al., 2017). We also investigated the fate
of these reactive EGCs when continually exposed to PAMPs or
DAMPs though a tunel assay to detect fragmented DNA.
We found that LPS or HMGB1 treated cells showed a
significant increase in co-localization events per 100 cells
compared to cells treated with only vehicle control (P = 0.043)
(Figures 14A–D). There was a significant decrease in tunel events
when cells were treated with LPS and Apocynin but not FBA. And
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Cytokines, ROS and growth factors etc affect tight junction
proteins, water channels and processes such as differentiation,
apoptosis etc. (Bush et al., 1998; Bush, 2002; Yu and Li, 2014).
In this study, we showed that when LPS primed intestinal
epithelial cells were treated with culture fluid from EGC,
there was a significant increase in mRNA expression of
proinflammatory cytokines in IEC-6 cells (Figure 14E)
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we chose to use two significant compounds that has been
studied for their TLR-antagonism (SSnB) and anti-inflammatory
properties (Sodium Butyrate-BT) specifically in the intestine.
Results showed that a combined use of TLR4 antagonist and
butyrate markedly increased aquaporin levels (Figure 15A) in
the small intestine when compared to GW-mice while levels
of Claudin-2 were significantly decreased in the small intestine
following SSnB + BT administration when compared to the
same group (Figure 15D). Occludin which is decreased in GW
mice and plays a significant role in maintaining gut barrier
integrity was also restored to normal levels in the diseased mice
following administration of SSnB + BT (Figure 15G). The results
suggested that blocking TLR4 and subsequent immunoactivation
that resulted in a reactive EGC phenotype in mice due to
dysbiosis can be reversed by the use of these antagonists. Also,
the results show that reactive EGCs might have a significant
role in causing gut barrier dysfunction following activation via
release of PAMPs and DAMPs and can be a cause of symptom
persistence in GWI.

Reactive EGC Modulate Tight Junction
Proteins and Aquaporins in Intestinal
Epithelial Cells

FIGURE 12 | Peroxynitrite formation in EGC. (A,B) Expression of 3NT in rat
EGC (n = 6). Immunoreactivity of 3NT was detected in vehicle (VEH), LPS,
LPS + APO, HMGB-1 and HMGB-1 + APO treated cells by staining with red
fluorescent antibody and counterstained with DAPI (blue) viewed at total
magnification 400X; scale 20 µm). (C,D) Morphometric analysis of 3NT in rat
EGC per 100 cells in different fields (∗ P < 0.05).

We investigated the hypothesis that EGC which are
exposed to DAMPS (e.g., HMGB-1) and PAMPS (e.g., LPS)
modulate intestinal tight junction proteins and selective
water channels by treating LPS primed IEC-6 cells with
culture fluids freshly collected from EGC which have been
treated with LPS (LPS-SN), HMGB1 (HMGB1-SN), vehicle
(VEH-SN), LPS + SsnB + Butyrate (LPS + SsnB + BT) or
HMGB1 + SsnB + Butryate (HMGB1 + SsnB + BT). Protein
expression was studied by immunofluorescence microscopy
observed at a total magnification of 400X; scale 10 µm.
We found that expression of aquaporin-3 was significantly
increased when IEC-6 cells were treated with LPS-SN, while
when they were treated withHMGB1-SN the expression was
significantly decreased compared to IEC 6 cells only treated
with vehicle control (VEH) (n = 3, p < 0.05). IEC-6 cells
treated which were treated with culture fluids from vehicle
control treated EGC (VEH-SN) showed only a slight increase
in aquaporin-3 protein expression, while IEC-6 cells treated
with inhibitors SsnB and Butyrate together with LPS or
HMGB1 restored expression of aquaporin 3 almost back
to similar levels as IEC-6 cells treated with vehicle control
(VEH) (Figures 16A,B). Claudin 2 expression increased
significantly when IEC-6 cells were treated with culture
fluids from EGC treated with LPS-SN (n = 3; p < 0.05), but
only markedly, when with HMGB1 treated culture fluids
(HMGB1-SN). And when IEC-6 cells were treated with culture
fluids for EGC treated with SsnB and butyrate together with
HMGB1 or LPS, claudin 2 levels were decreased similar
to vehicle control treated cells (VEH) (Figures 16C,D).
Higher magnification (630X and scale bar 20 µm) images
taken under confocal microscopy are included to show the
localization of this protein in the membrane (Figure 17A).
IEC-6 cells that were treated with culture fluids from EGC

(P < 0.05). LPS primed IEC-6 cells which were treated
with culture fluids from EGC treated with LPS (LPS-SN) showed
a significant increase in mRNA expression of IL-1β, MCP1 and
TNF-α when compared to the vehicle control (VEH) (P < 0.05).
LPS primed cells treated with culture fluids from Vehicle control
treated EGC showed a significant decrease in MCP-1 expression
(P < 0.05) and a marked decrease in TNF-α but no significant
decrease in IL-1β expression compared to the LPS primed IEC-6
cells treated with culture fluids from LPS treated EGC.
To ensure that EGC immune activation via an altered
microbiome plays a significant role in gut barrier protein
expression in the intestine, we studied the GW chemical
treated mice for their protein levels of aquaporin, a selective
water channel, occludin and claudin-2. Results showed that
administration of antibiotics was associated with significantly
restored the levels of aquaporin 3 in the intestine of GWItreated mice when compared to GW-treatment (Figures 15A–
C). Levels of occludin were also restored when compared to
controls but were significantly elevated when compared to GWmice only (Figures 15D–F). Claudin-2 levels have been found
to be increased in association with gut integrity loss. Our results
showed that use of antibiotics significantly decreased the levels of
claudin-2 in antibiotic treated mice when compared to GWI-mice
alone (Figures 15G–I).
To show that EGC immune activation as a result of TLR4
and specific inflammation was responsible in part in causing
differential expression of tight junction proteins that may
play a significant role in gut barrier protein integrity loss,
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FIGURE 13 | ROS mediated activation of NLRP-3 inflammasome and inflammation in EGC. (A,B) Quantitative real time PCR (qRT-PCR) analysis of inflammasome
and inflammation (n = 6). mRNA expression of NLRP-3, caspase-1, IL-1β and TNF-α in rat EGC which were treated with vehicle (VEH), LPS + apocynin
(LPS + APO), LPS + phenylboronic acid (LPS + FBA), HMGB-1, HMGB-1 + APO. mRNA expression is represented as a fold change of the vehicle control. Data
points are represented as mean ± SEM (n = 3) (∗ P > 0.05). (C) NLRP-3/ASC2 protein expression in rat EGC assessed by immunofluorescence microscopy and
viewed at total magnification 400X; scale 20 µm). Colocalization events were determined for every 100 cells per field in cells treated with LPS, LPS + APO,
LPS + FBA, HMGB-1, HMGB-1 + APO, HMGB1 + FBA. (D,E) Quantitative morphometric analysis of fluorescence intensity of NLRP-3/ASC2. Fields for
morphometric analysis were randomly selected from different fields per slide and represented as% region of interest (% ROI) (∗ P < 0.05).

treated with LPS (LPS-SN) or HMGB1(HMGB1-SN) showed a
significant decrease in occludin protein expression compared
to vehicle control treated IEC-6 cells (VEH) (Figures 16E,F).
Treatment with culture fluids from EGC which had been
treated with LPS or HMGB1 together with inhibitors (SsnB
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and butyrate) showed a restoration in occludin levels compared
to the control (VEH), although the effect was stronger in
IEC 6 cells treated with LPS + SsnB + BT compared to
HMGB1 + SsnB + BT treated EGC culture fluids. Higher
magnification (630X and scale;20 µm) images taken under
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FIGURE 14 | DNA fragmentation of rat EGC. (A,B) Tunel assay showing DNA fragmentation (n = 6). DNA fragmentation was determined by the Tunel assay in
Vehicle (VEH), LPS, LPS + APO, LPS + FBA, HMGB-1, HMGB-1 + APO, HMGB-1 + FBA treated cells viewed at total magnification 400X; scale 10 µm. (C,D)
Quantitative morphometric analysis of fluorescence expression of Tunel positive cells represented as Tunel events per field (∗ P < 0.05). (E) Effect of EGC culture
fluids on LPS primed intestinal epithelial cells. mRNA expression of IL-1β, MCP-1 and TNF-α in IEC-6 cells which have been primed with LPS and treated with
culture fluids from EGC treated with LPS and vehicle control (n = 6) represented as x Fold of the vehicle control.

confocal microscopy were used to show the localization of
this protein in the membrane (Figures 17A,B). The tubulin
staining used in occludin images to show the extent of
occludin traversing the tubulin outline thus signifying their
apical membrane localization as widely perceived (Shown
by white arrows).
These results indicate that reactive EGC are strong players
in modulating tight junction protein expression through
production of factors that may influence gut barrier integrity.
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DISCUSSION
Our results propose a possible molecular mechanism to explain
the altered microbiome associated inflammation in a cellular
level and poor gastrointestinal health which we observed in
our studies on GWI (Alhasson et al., 2017; Seth et al., 2018).
The results reported in this study are an advancement to our
previous reported work in Gulf War illness pathology. Since
gut sterility by antibiotics reversed immunopathology in GWI
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FIGURE 15 | Expression of claudin 2, occludin and aquaporin 3 in mouse small intestine. (A,D,G) Protein expression of occludin, claudin 2 and aquaporin 3 in
mouse small intestine was determined by immunofluorescence microscopy and visualized at total 200X; scale 50 µm in tissues obtained from mice treated with
vehicle control (CONT, n = 6); mice treated with GW chemicals (GW, n = 9) mice co-exposed with GW chemicals and antibiotics (GW + AB, n = 9) and mice treated
with GW chemicals, Sparstolonin B (SsnB) and Sodium butyrate (GW + SsnB + BT) (n = 6). (C,F,I) Higher magnification images for GW chemical treated group (GW)
focusing on the apical or apical-lateral membranes total magnification 600X; scale 20 µm). (B,E,H) Quantitative morphometric analysis of immunoreactivity of
occludin or aquaporin 3 is represented as (% ROI) (∗ P < 0.05).

we used the same approach to correlate the observed gut
dysbiosis with EGC immunoactivity. We found a novel role
of altered microbiome in causing a reactive EGC phenotype
characterized by activation of toll-like receptors, RAGE/S100B
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and increased expression of nitric oxide synthase. This pathway
contributes to NADPH oxidase mediated generation of ROS
which trigger inflammation. The mechanism of NOX2 mediated
inflammation is well accepted as we and others have shown the
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FIGURE 16 | Protein expression of aquaporin 3, claudin 2 and occludin in intestinal epithelial cells. (A,C,E) Protein expression of aquaporin-3, claudin-2, and
occludin in IEC 6 cells treated with culture fluids from Vehicle (VEH-SN), LPS (LPS-SN), HMGB1 (HMGB1-SN) and inhibitors SsnB and butyrate (LPS + SsnB + BT
and HMGB1 + SsnB + BT) treated EGC. The expression of these proteins was studied by immunofluorescence microscopy and viewed at 400X total magnification;
scale 10 µm. Yellow arrows indicate the localization of the proteins in the cell membrane. (B,D,F) Quantitative morphometric analysis of immunoreactivity of
aquaporin, claudin 2, and Occludin represented as (% ROI) (n = 3, ∗ P < 0.05).
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et al., 2017; Seth et al., 2018) (Supplementary Figure S1).
We found an increase in the Firmicutes/Bacteriodetes ratio
with significant increases in several Firmicutes genera in gulf
war chemical treated mice compared to the vehicle controls.
Further we found an associated loss in bacteria populations such
as Bacteroides, Oscillibacter and Ruminiclostridia. Increased
abundance of Bacteroides for example are associated with healthy
gastrointestinal states (Johnson et al., 2017), while Oscillibacter
and Ruminiclostridia have also been shown to be abundant in
healthy controls in studies of Crohn’s disease (Svolos et al., 2019).
The decline in beneficial microbiota may have allowed for the
proliferation of several bacteria populations at genus level, which
usually exist in low percentages. There was a rise in several
Coriobacteria, Bacilli and Verrucomicrobia bacteria. These have
all been associated to increase in IBS and IBD (Distrutti et al.,
2016). This upset balance of bacteria population dynamic results
in normally benign bacterial populations to become pathogenic
and could cause EGC to change to a reactive phenotype through
toll-like receptor signaling (Zhang et al., 2015).
Both the altered microbiome and reactive EGC phenotypes
have been linked to several diseased states of the gut such as
IBS, IBD, gut hypersensitivity etc. (Conlon and Bird, 2014; Wang
et al., 2019). However, there is scanty information concerning the
true mechanism of how they contribute to these diseases. Our
current study showed a correlation between altered microbiome
and a reactive EGC phenotype in small intestine. Mice treated
with GW chemicals (GW) had a higher expression of GFAP a
protein whose increased expression has been associated with IBS,
S100β/RAGE complex formation and finally an increase in nitric
oxide synthase activity in EGC. These proteins were not increased
in vehicle control treated mice (CONT) and their expression
was significantly less in mice treated with GW chemicals and
antibiotics (GW + AB). This emphasizes the role of microbiome
in contributing to EGC reactive phenotype. Though we have
used antibiotics to ensure gut contamination or sterility, the use
of such approach may not be ensuring complete gut sterility
in mice. Often the use of such antibiotics can selectively lead
to bacteriostatic effects in healthy fauna while elevating the
abundance of harmful bacteria in the gut. The use of germ
free mice is the best approach for conducting studies where
the endpoint is to assess the role gut bacteria in the pathology.
Though it has to be admitted that antibiotic use for ensuring
gut sterility is a standard approach where use of germ-free mice
is a constraint. The use of antibiotics in our study is thus a
limitation and needs further corroborative studies in future using
the germ free model.
Mechanistically, we showed that the increased activation
of NOX-2 following an altered microbiome and associated
activation of the EGCs in GW chemical exposed mice plays
a significant role in contributing to the observed intestinal
inflammatory phenotype. NOX-2 in EGC and in adjacent
intestinal cells, participates in oxidative stress which results from
the increase in nitric oxide production. We found that the
generated ROS triggered activation of the NLRP-3 inflammasome
which further caused increase in inflammation and programmed
cell death as showed by increased DNA fragmentation (tunel
assay) in rat EGCs stimulated with LPS and/or HMGB1.

FIGURE 17 | Cellular localization of Claudin 2 (A) and Occludin (B) protein
expression in intestinal epithelial cells via confocal microscopy. Protein
expression of Claudin 2 (A) or Occludin (B) in the cell membrane of intestinal
epithelial cells treated with culture fluids from EGC treated with Vehicle
(VEH-SN), LPS (LPS-SN) and LPS with SsnB and butyrate (LPS + SsnB +
BT). The images were viewed under a confocal microscope at a total
magnification of 630X and scale 20 µm. Occludin membrane localization was
based on the tubulin staining that visualizes the outline of the cell.

role of peroxynitrite mediated inflammation in liver, kidney and
gastrointestinal disturbances (Das et al., 2015; Alhasson et al.,
2016) Further, we propose that this increased inflammation and
ROS may result in enteric gliopathy and a later episodes of enteric
neuropathy although this needs to be investigated further and
is a speculation at this point. With continued production of
proinflammatory cytokines and other destructive factors (e.g.,
ROS) by reactive EGC, the entire or part of the epithelial barrier
in the gut might lose its integrity. This hypothesis is further
strengthened by our results from the supposed blockage of TLR4
and inflammation by using SSnB and Butyrate (thus blocking
EGC immune-activation), further exacerbating the observed
gastrointestinal pathology in gulf war illness. This explanation
not only helps us understand the acute phase of gulf war
associated gastrointestinal inflammatory disorders, but also could
explain why these symptoms may persist for long since a vicious
cycle might exist following a continuous assault on the intestinal
epithelial cells.
Enteric glial cells are important regulators of the
gastrointestinal tract health. They can influence the gut
microenvironment both positively or negatively depending on
surrounding conditions (Capoccia et al., 2015; Ochoa-Cortes
et al., 2016; Grubisic et al., 2018). Remarkably they can respond
to the presence of bacteria pathogens through this TLRRAGE/S100β-iNOS pathway. This is through the recognition
of bacterial parts such as cell wall, high bacterial populations,
DNA etc via toll like receptors. With an altered microbiome,
there is proliferation of certain bacterial species at the expense
of others and this change upsets the natural healthy balance in
microbiome. This disruption happens due to several stressful
stimuli e.g., infection, diet or exposure to chemicals such as in
the case of gulf war illness.
Our previous studies have clearly shown that exposure to
GW chemicals indeed results in altered microbiome (Alhasson
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oxide production, formation of peroxynitrite, a redox signaling
intermediate and inflammation pathways as therapeutic targets
in gulf war illness.

This increased inflammation and direct loss in enteric glia
has been reported as in Chron’s disease (Cornet et al., 2001;
Ochoa-Cortes et al., 2016). The reactive inflammatory glial
phenotype is detrimental to the health of the gastrointestinal
tract because it produces destructive factors which interact with
surrounding cells in the intestine e.g., intestinal epithelial cells,
enteric neurons etc. In our study we showed that when EGC
conditioned media was applied to primed epithelial cells, there
was an increase in proinflammatory cytokine expression such
as IL1β, MCP-1 and TNF-α which can be conducive to a leaky
gut microenvironment. Furthermore, we observed that a reactive
EGC phenotype can also have detrimental effects on the EGCs as
shown by increased DNA fragmentation and cell death through
the increased inflammation and ROS generated. This ultimately
may result in programmed cell death in glia by pyroptosis or
apoptosis as shown elsewhere (Macchioni et al., 2017). The
general loss in enteric glia could lead to suboptimal functioning
of enteric neurons and even enteric neuropathy (Bassotti et al.,
2018). This mechanism could be a possible explanation for the
symptoms of GWI which continue to persist for 25 years though
the present report does not study the role of an activated EGC
on intestinal neurons. However, the effect of the reactive EGCs
on intestinal epithelial cell barrier integrity can be profound
as a blockade of the EGC activation mechanisms by SSnB and
butyrate prevented protein alterations in the tight junctions. The
results are also interesting since we observe a cyclical pattern of
epithelial cell damage-activation of EGCs and a link to altered
expression of tight junction proteins such as claudin-1,2, occludin
or ZO-1 that may contribute to gut-leakiness, that eventually
might fuel a continuous persistence of inflammation in the local
intestinal microenvironment.
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CONCLUSION
We report that EGC are important players in GWI
gastrointestinal disease pathology and respond to the altered
microbiome in the host gut by converting to a reactive
phenotype which greatly affects the healthy functioning of the
gastrointestinal tract. This reactive phenotype significantly
contributes to oxidative stress which further triggers
inflammation, loss of gut barrier integrity and possibly death of
enteric glia and enteric neurons, although further investigations
need to be carried out to confirm these neuronal effects. Further,
these findings provide insights into how a possible altered
microbiome may be contributing to the observed GWI intestinal
epithelial cell inflammatory phenotype by destabilizing the
redox status of glial cells and adjacent epithelial cells via NOX-2
mediated peroxynitrite generation, inflammasome activation and
release of pro inflammatory cytokines. It has to be further realized
that more concrete evidence will be needed that involves germ
free mice to conclude with certainty that microbiome alterations
definitely dictate the observed EGC effects and therefore remains
a limitation in this study. Antibiotic use for gut sterility should
be overcome with more stringent experimental designs such as
germ-free mouse models and gnotobiotic mice. Nevertheless, the
present evidence will therefore be valuable to consider EGC nitric
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